In a statement, Merck said regulatory agencies have continued to conclude HPV vaccines are safe and effective, as have 30 years of research. Clinical trials have included over 70,000 people with ...

Merck’s earnings estimates for 2025-2030 were lowered, with 2030 EPS now forecast to be significantly below 2024 levels. TD Cowen cut its price target on Merck from $121 to $100, citing weaker ...

On TikTok, there are videos where women talk directly to the camera. They promote the "natural remedies" they say cleared their infections and discuss "holistic healing" recommendations.

Shares of Merck slid Tuesday after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales forecast due partly to a pause in shipments of one of its top-selling products to China.

Investing.com -- TD Cowen downgraded Merck & Company Inc (NYSE:MRK) to "Hold" on concerns over uncertainty surrounding Gardasil sales, a slowdown in business development, and the looming loss of ...

Investing.com -- TD Cowen downgraded Merck &Company Inc (NYSE:MRK) to "Hold" on concerns over uncertainty surrounding Gardasil sales, a slowdown in business development, and the looming loss of ...

As part of the announcement, Merck disclosed setbacks to Gardasil's sales, highlighting a 3% decrease in sales in 2024 and, more directly, a decrease of 18% in the fourth quarter, with the blame ...

We recently published a list of Jim Cramer Discussed These 12 Stocks Recently. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other stocks that ...

Eduardo Franco has served as an occasional paid consultant to pharmaceutical and biotechnology companies involved with HPV vaccines (GSK, Merck), HPV ... by the US FDA for commercial use in ...

Merck & Co., Inc. (NYSE ... expecting a strong performance from Keytruda and Gardasil, a lack of major risks, and management’s efforts to extend Keytruda’s outlook. However, concerns over ...